Opportunity Information: Apply for CDC RFA PS15 1509
Apply for CDC RFA PS15 1509
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color at Risk for and Living with HIV Infection" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.940 HIV Prevention ActivitiesHealth Department Based.
- This funding opportunity was created on May 7, 2015 and posted on Mar 31, 2015.
- Applicants must submit their applications by Jun 1, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $14,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,333,333.00 in funding.
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: State governments County governments City or township governments.
- 1. Eligible Applicants Applicants must meet one of the following two criteria Morbidity Criteria Metropolitan Statistical Areas/Divisions with gt2,000 Black and/or Hispanic MSM living with diagnosed HIV o Focuses on MSA targets areas where most MSM are accessible o Threshold of 2,000 ensures a large participant pool to robustly demonstrate the prevention and care service models Mortality Criteria States in the 4th quartile for mortality rates as reported in the State Progress Report and have gt1,000 Black and/or Hispanic MSM living with diagnosed HIV in a specified MSA Jurisdictions eligible under the morbidity criteria cannot apply under the mortality criteria. State health departments with one eligible MSA are required to work in the specified eligible MSA or MD. States that have more than one eligible MSA may elect to work in all or a reduced number of eligible MSAs, in order of prevalence unless one MSA/MD declines to participate. States that have local health departments directly funded by CDC are not eligible to apply for the MSAs or MDs that contain locally funded health departments within the state. Funding will be awarded to up to 2 health department that meets the Mortality Criteria. CDC will not consider any application that is submitted after the due date of June 1, 2015, 1159 p.m. U.S. Eastern Standard Time incomplete missing descriptions of any of the required 24 services for comprehensive HIV prevention and care (Strategies and Activities section) or missing MOAs, MOUs, or letters of support for service agreements from each collaborative partner except the CBO partner(s). (Strategies and Activities section). Please see additional information on eligiblity criteria in Section 3 Justification for Less than Maximum Competition
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA PS15-1509) is a CDC cooperative agreement designed to reduce the impact of HIV among men who have sex with men (MSM) of color, with a particular focus on Black and Hispanic MSM who are either at substantial risk for acquiring HIV or who are living with HIV. The core idea is to fund a small number of health departments to build and run demonstration projects that pull together comprehensive, coordinated services across HIV prevention, HIV medical care, behavioral health, and related social supports. The intent is not just to offer isolated interventions, but to test real-world service models that are integrated and easier for people to navigate, ideally improving outcomes like prevention uptake, retention in care, and viral suppression. While the projects must prioritize MSM of color, the announcement explicitly states that services cannot be denied to anyone based on race, ethnicity, or other demographic factors, and programs may also serve other people at risk for HIV or people living with HIV who are not virally suppressed.
The opportunity is categorized as discretionary funding and uses a cooperative agreement mechanism, which typically means CDC expects to have substantial involvement during the project period (for example, providing technical assistance, guiding evaluation expectations, and monitoring progress). The funding activity is tied to CFDA 93.940 (HIV Prevention Activities), and the program anticipated making about six awards. The estimated total funding amount was $14,000,000, with individual awards expected to range from $1,750,000 (floor) to $2,333,333 (ceiling). There is no cost-sharing or matching requirement, which reduces the need for applicants to bring non-federal dollars to the table.
Eligible applicants are governmental health departments at the state, county, or city/township level, but eligibility is narrowed further using epidemiologic criteria so that the funded demonstrations occur in jurisdictions with a sufficiently large affected population and/or high HIV-related mortality burden. The first pathway is a morbidity-based eligibility route focused on Metropolitan Statistical Areas (MSAs) or Metropolitan Divisions (MDs) with more than 2,000 Black and/or Hispanic MSM living with diagnosed HIV. The rationale given is practical: concentrating on large MSAs/MDs increases the likelihood that MSM are accessible for engagement and ensures a large enough participant pool to demonstrate and evaluate the comprehensive prevention and care models in a meaningful way. The second pathway is a mortality-based route for states in the fourth quartile for HIV-related mortality rates (as reported in the State Progress Report) that also have more than 1,000 Black and/or Hispanic MSM living with diagnosed HIV in a specified MSA. Importantly, a jurisdiction that qualifies under the morbidity criteria is not allowed to apply under the mortality criteria, and CDC planned to award funding to up to two health departments under the mortality criteria specifically.
The announcement also sets several jurisdiction-structure rules that affect who can apply and where work must occur. State health departments that have only one eligible MSA are required to implement the project in that specified eligible MSA/MD. States with more than one eligible MSA may choose to work in all eligible MSAs or select a smaller set, generally in order of HIV prevalence, unless an MSA/MD declines to participate. Another major limitation is intended to avoid overlap with CDC-funded local jurisdictions: states that contain local health departments that are directly funded by CDC are not eligible to apply for the MSAs/MDs that include those locally funded health departments.
A defining feature of the FOA is the required collaborative model. Health departments are expected to formally partner with community-based organizations (CBOs) and clinics and/or health care providers to deliver a comprehensive package of services. The expectation is that the collaborative collectively delivers a full set of required program elements, rather than leaving all responsibilities to a single agency. This is framed as a way to address the multiple, connected needs that affect HIV risk and HIV outcomes in MSM of color, including not only access to testing and biomedical prevention or treatment, but also behavioral health needs and social service barriers that can disrupt prevention adherence or HIV care engagement.
The FOA places strong emphasis on completeness and documented partnerships at the time of application. CDC stated it would not consider late applications (after June 1, 2015, 11:59 p.m. Eastern Time). It also specified that applications could be deemed nonresponsive if they were incomplete, including if they were missing descriptions of any of the required 24 services that make up the comprehensive HIV prevention and care approach. In addition, the application needed formal agreements or documentation (such as memoranda of agreement, memoranda of understanding, or letters of support) to show that service arrangements were in place with each collaborative partner, with an exception noted for CBO partner(s). In other words, the program was not looking for informal or tentative partnerships; it required evidence that the collaborative was ready to operate and able to deliver the full service set.
From an administrative standpoint, the opportunity was posted March 31, 2015, with an original and current closing date of June 1, 2015, and an archive date of July 1, 2015. The main program goal is straightforward: reduce HIV burden among MSM of color by implementing and demonstrating coordinated prevention and care models that are comprehensive enough to address clinical, behavioral, and social factors together, while still ensuring services remain accessible to anyone who needs them. For questions or access issues related to the full announcement, the listed CDC contact was Brian Kolodziejski (bsp3@cdc.gov) in Grants Policy.
Frequently Asked Questions (FAQs) - CDC RFA PS15-1509
What is CDC RFA PS15-1509?
CDC RFA PS15-1509 is a CDC cooperative agreement funding opportunity intended to support demonstration projects that reduce the impact of HIV among men who have sex with men (MSM) of color, with particular focus on Black and Hispanic MSM who are at substantial risk for acquiring HIV or who are living with HIV.
What is the main goal of this funding opportunity?
The main goal is to reduce HIV burden among MSM of color by implementing and demonstrating coordinated prevention and care models that bring together comprehensive services across HIV prevention, HIV medical care, behavioral health, and related social supports.
What type of funding mechanism is this?
This opportunity uses a cooperative agreement mechanism. That typically means CDC expects to have substantial involvement during the project period, such as providing technical assistance, guiding evaluation expectations, and monitoring progress.
Is this discretionary funding?
Yes. The opportunity is categorized as discretionary funding.
What CFDA program is this tied to?
The funding activity is tied to CFDA 93.940, HIV Prevention Activities.
How many awards were anticipated?
CDC anticipated making about six awards.
How much total funding was estimated for this opportunity?
The estimated total funding amount was $14,000,000.
What was the expected funding range per award?
Individual awards were expected to range from $1,750,000 (floor) to $2,333,333 (ceiling).
Is there a cost-sharing or matching requirement?
No. The announcement stated there is no cost-sharing or matching requirement.
Who is eligible to apply?
Eligible applicants are governmental health departments at the state, county, or city/township level. Eligibility is further narrowed by epidemiologic criteria so that funded projects occur in jurisdictions with sufficiently large affected populations and/or high HIV-related mortality burden.
What are the two eligibility pathways described in the announcement?
The announcement described two routes: (1) a morbidity-based eligibility pathway for MSAs/MDs with more than 2,000 Black and/or Hispanic MSM living with diagnosed HIV, and (2) a mortality-based eligibility pathway for states in the fourth quartile for HIV-related mortality rates (per the State Progress Report) that also have more than 1,000 Black and/or Hispanic MSM living with diagnosed HIV in a specified MSA.
Can an applicant choose between the morbidity and mortality eligibility pathways?
Not freely. A jurisdiction that qualifies under the morbidity criteria is not allowed to apply under the mortality criteria.
How many awards were planned under the mortality criteria?
CDC planned to award funding to up to two health departments under the mortality criteria.
What is the morbidity-based eligibility threshold?
The morbidity-based route focused on MSAs or Metropolitan Divisions with more than 2,000 Black and/or Hispanic MSM living with diagnosed HIV.
What is the mortality-based eligibility threshold?
The mortality-based route applied to states in the fourth quartile for HIV-related mortality rates (per the State Progress Report) that also have more than 1,000 Black and/or Hispanic MSM living with diagnosed HIV in a specified MSA.
Where must funded work occur?
Funded work must occur in the eligible jurisdiction(s) described in the application, consistent with the announcement's rules about eligible MSAs/MDs and state/local jurisdiction structure.
What if a state health department has only one eligible MSA?
If a state health department has only one eligible MSA, it is required to implement the project in that specified eligible MSA/MD.
What if a state has more than one eligible MSA?
States with more than one eligible MSA may choose to work in all eligible MSAs or select a smaller set, generally in order of HIV prevalence, unless an MSA/MD declines to participate.
Are there restrictions related to CDC-funded local jurisdictions?
Yes. States that contain local health departments directly funded by CDC are not eligible to apply for the MSAs/MDs that include those locally funded health departments.
Who is the program intended to prioritize?
The projects must prioritize MSM of color, with a particular focus on Black and Hispanic MSM who are at substantial risk for acquiring HIV or who are living with HIV.
Can services be denied to people who are not MSM of color?
No. The announcement explicitly stated that services cannot be denied to anyone based on race, ethnicity, or other demographic factors.
Can the program serve people other than MSM of color?
Yes. The announcement stated that programs may also serve other people at risk for HIV or people living with HIV who are not virally suppressed, as long as MSM of color remain the priority population.
What is meant by a "demonstration project" in this FOA?
In this context, the intent is to fund a small number of health departments to build and run real-world, integrated service models that are easier for people to navigate, rather than delivering isolated interventions.
What kinds of services are expected to be integrated?
The core model is described as comprehensive and coordinated across HIV prevention, HIV medical care, behavioral health, and related social supports.
What outcomes is the FOA trying to improve?
The announcement indicates an intent to improve outcomes such as prevention uptake, retention in care, and viral suppression.
Are partnerships required?
Yes. Health departments are expected to formally partner with community-based organizations (CBOs) and clinics and/or health care providers to deliver a comprehensive package of services.
Does the collaborative need to deliver all required program elements?
Yes. The expectation is that the collaborative collectively delivers the full set of required program elements, rather than leaving all responsibilities to a single agency.
What documentation of partnerships was required at the time of application?
The application needed formal agreements or documentation (for example, memoranda of agreement, memoranda of understanding, or letters of support) showing service arrangements were in place with each collaborative partner. An exception was noted for CBO partner(s).
How strict was CDC about application completeness?
The FOA emphasized completeness. Applications could be deemed nonresponsive if incomplete, including if they were missing descriptions of any of the required 24 services that make up the comprehensive HIV prevention and care approach.
What happens if an application is submitted after the deadline?
CDC stated it would not consider late applications submitted after June 1, 2015, 11:59 p.m. Eastern Time.
What were the key dates for this funding opportunity?
The opportunity was posted March 31, 2015. The original and current closing date was June 1, 2015. The archive date was July 1, 2015.
Who was listed as the CDC contact for questions or access issues?
The listed CDC contact was Brian Kolodziejski (bsp3@cdc.gov) in Grants Policy.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Chemical Stockpile Emergency Preparedness Program
Previous opportunity: Domestic Laboratory Biosafety for Ebola and other Highly Infectious Diseases
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 1509
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 1509) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIAMS Clinical Trial Planning Cooperative Agreement (U34) Apply for PAR 15 166 Funding Number: PAR 15 166 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Preventive Medicine Residency with Integrative Health Care Training Program Apply for HRSA 15 143 Funding Number: HRSA 15 143 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons Apply for CDC RFA PS15 1506 Funding Number: CDC RFA PS15 1506 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,000,000 |
| Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection Apply for CDC RFA PS15 1510 Funding Number: CDC RFA PS15 1510 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Request for Information for RFI 674 15 RHAP 001 Apply for RFI 674 15 RHAP 001 Funding Number: RFI 674 15 RHAP 001 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 15 164 Funding Number: PAR 15 164 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Training and Technical Assistance Cooperative Agreements (NCAs) Apply for HRSA 15 140 Funding Number: HRSA 15 140 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 15 165 Funding Number: PAR 15 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Health Action Learning Initiative (THALI) Apply for RFA 386 15 000001 Funding Number: RFA 386 15 000001 Agency: India USAID New Delhi Category: Health Funding Amount: $9,500,000 |
| NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 15 167 Funding Number: PAR 15 167 Agency: National Institutes of Health Category: Health Funding Amount: $70,000 |
| PPHF 2015 Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention (PPHF 2015) Apply for SM 15 004 Funding Number: SM 15 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $736,000 |
| Alzheimers Drug Development Program (U01) Apply for PAR 15 174 Funding Number: PAR 15 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| PPHF 2015 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self Management Education Programs Financed Solely by 2015 Prevention and Public Health Funds (PPHF 2015) Apply for HHS 2015 ACL AOA CS 0094 Funding Number: HHS 2015 ACL AOA CS 0094 Agency: Administration for Community Living Category: Health Funding Amount: $900,000 |
| Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II Apply for RFA CK 15 004 Funding Number: RFA CK 15 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,200,000 |
| Native Hawaiian Health Care Improvement Act Apply for HRSA 15 017 Funding Number: HRSA 15 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01) Apply for PAR 15 172 Funding Number: PAR 15 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co Infections (R01) Apply for RFA DE 16 002 Funding Number: RFA DE 16 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pre Application for Collaborative Innovation Award, CTSA Program (X02) Apply for PAR 15 173 Funding Number: PAR 15 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42) Apply for RFA AT 16 004 Funding Number: RFA AT 16 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R43/R44) Apply for RFA AT 16 003 Funding Number: RFA AT 16 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 1509", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.